Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Reduced antigenicity – reduced ability to bind complement – or...
Patent
1976-09-27
1977-12-06
Rosen, Sam
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Reduced antigenicity, reduced ability to bind complement, or...
195 17, 260112B, 2601125R, 424101, A61K 3702, C12B 300, C07G 700
Patent
active
040617360
ABSTRACT:
This invention concerns pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin. The intramolecularly cross-linked, stromal-free hemoglobin is useful as a blood substitute for carrying oxygen to tissues and vital organs, as a blood plasma expander, and for supplying oxygen to oxygen-requiring environments.
REFERENCES:
patent: 4001200 (1977-01-01), Bonsen et al.
patent: 4001401 (1977-01-01), Bonsen et al.
Bonsen Pieter
Laver Myron B.
Morris Kent C.
ALZA Corporation
Ciotti Thomas E.
Mandell Edward L.
Rosen Sam
Sabatine Paul L.
LandOfFree
Pharmaceutically acceptable intramolecularly cross-linked, strom does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically acceptable intramolecularly cross-linked, strom, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically acceptable intramolecularly cross-linked, strom will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1551030